Prognostic factors and a predictive model of follicular lymphoma: A 25-year study at a single institution in Japan

Japanese Journal of Clinical Oncology

Volumn 26, Issue 6, 1996, Pages 445-454

  Katsumata, Noriyuki ^a   Matsuno, Yoshihiro ^b   Nakayama, Hidetsugu ^b   Takenaka, Takeaki ^a   Kobayashi, Yukio ^a   Takeyama, Kunihiko ^a   Narabayashi, Masaru ^a   Fukushima, Takuya ^a   Yokozawa, Toshiya ^a   Nakata, Masanobu ^a   Tajima, Kinuko ^a   Ikeda, Hiroshi ^a   Tobinai, Kensei ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Follicular lymphoma; Histologic review; Predictive model; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; COP PROTOCOL 1; CYCLOPHOSPHAMIDE; DOXORUBICIN; HYDROCORTISONE; METHOTREXATE; METHYLPREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; HYDROCORTISONE; LYMPHOMA, FOLLICULAR; MALE; METHOTREXATE; METHYLPREDNISOLONE; MIDDLE AGED; NEOPLASM STAGING; PROCARBAZINE; PROGNOSIS; SURVIVAL RATE; VINCRISTINE;

EID: 0030332496     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jjco.a023262     Document Type: Article

References (48)

1. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke R: Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16: 637-640, 1992
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392, 1994
3. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM: A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 85: 1075-1082, 1995
4. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 49: 2112-2135, 1982
5. Metter GE, Nathwani BN, Burke JS, Winberg CD, Mann RB, Barcos M, Kjeldsberg CR, Whitcomb CC, Dixon DO, Miller TP, Jones SE: Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists: a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol 3: 25-38, 1985
6. Nathwani BN, Metter GE, Miller TP, Burke JS, Mann RB, Barcos M, Kjeldsberg CR, Dixon DO, Winberg CD, Whitcomb CC, Jones SE: What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood 68: 837-845, 1986
7. Bartlett NL, Rizeq M, Dorfman RF, Halpern J, Horning SJ: Follicular large-cell lymphoma: intermediate or low grade? J Clin Oncol 12: 1349-1357, 1994
8. Martin AR, Weisenburger DD, Chan WC, Ruby EI, Anderson JR, Vose JM, Bierman PJ, Bast MA, Daley DT, Armitage JO: Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 85: 3671-3678, 1995
9. Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H: Non-Hodgkin's lymphomas: IV. clinicopathologic correlation in 405 cases. Cancer 31: 806-823, 1973
10. Ho FC, Todd D, Loke SL, Ng RP, Khoo RK: Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: retrospective study covering an eight-year period. Int J Cancer 34: 143-148, 1984
11. Su IJ, Shin LY, Kadin ME, Dun P, Hsu SM: Pathologic and immunologic characterization of malignant lymphoma in Taiwan: with special reference to retrovirus-associated adult T-cell lymphoma/leukemia. Am J Clin Pathol 84: 715-723, 1985
12. The Nationwide Lymphoma Pathology Cooperative Group (NLPCG): A retrospective histological study of 9,009 cases of malignant lymphoma in China using the NLPCG classification. Jpn J Clin Oncol 15: 645-651, 1985
13. Ohsawa M, Aozasa K, Tsujimura T, Ikeda H, Tsujimura T: Non-Hodgkin's lymphomas of follicular center cell type in Osaka, Japan. Eur J Cancer Clin Oncol 25: 1875-1878, 1989
14. Kadin ME, Berard CW, Nanba K, Wakasa H: Lymphoproliferative diseases in Japan and western countries. Hum Pathol 14: 745-772, 1983
15. Amakawa R, Fukuhara S, Ohno H, Doi S, Oguma S, Tanabe S, Yamabe H, Edamura S, Tomono N, Nasu K, Konaka Y, Shiomura T, Abe M, Wakasa H, Uchino H: Involvement of bcl-2 gene in Japanese follicular lymphoma. Blood 73: 787-791, 1989
16. Mitani S, Aoki N, Mizutani S, Fujiwara M, Kitagawa T, Uehara T, Mori S: bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens. Jpn J Cancer Res 84: 37-41, 1993
17. Osada H, Seto M, Ueda R, Emi N, Takagi N, Obata Y, Suchi T, Takahashi T: bcl-2 gene rearrangement analysis in Japanese B cell lymphoma: novel bcl-2 recombination with immunoglobulin kappa chain gene. Jpn J Cancer Res 80: 711-715, 1989
18. Liang R, Chan V, Chan TK, Chiu E, Todd D: Rearrangement of immunoglobulin, T-cell receptor, and bcl-2 genes in malignant lymphomas in Hong Kong. Cancer 66: 1743-1747, 1990
19. Loke SL, Pittaluga S, Srivastava G, Raffeld M, Ho FC: Translocation of bcl-2 gene in non-Hodgkin's lymphomas in Hong Kong Chinese. Br J Hematol 76: 65-69, 1990
20. Dorfman RF: Letter: Classification of non-Hodgkin's lymphomas. Lancet 1: 1295-1296, 1974
21. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31: 1860-1861, 1971
22. Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Ogawa M, Kimura I, Tominaga S, Tsugane S, Taguchi H, Minato K, Takenaka T, Tobinai K, Kurita S, Oyama A, Hisano S, Kozuru M, Matsumoto M, Nomura K, Takiguchi T, Sugai S, Yamaguchi K, Hattori T, Kinoshita K, Tajima K, Suemasu K for the Lymphoma Study Group (1981-1983): Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol 6: 128-141, 1988
23. Tobinai K, Shimoyama M, Minato K: Japan Clinical Oncology Group (JCOG) phase II trial of second-generation "LSG4 protocol" in aggressive T- and B-lymphoma: a new predictive model for T- and B-lymphoma (Abstract). Proc Am Soc Clin Oncol 14: 378, 1994
24. WHO Handbook for Reporting Results of Cancer Treatment, WHO, Geneva. 1979
25. Dixon DO, McLaughlin P, Hagemeister FB, Freireich EJ, Fuller LM, Cabanillas FF, Gehan EA: Reporting outcomes in Hodgkin's disease and lymphoma. J Clin Oncol 5: 1670-1672, 1987
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
27. Coiffier B, Bastion Y, Berger F, Felman P, Bryon PA: Prognostic factors in follicular lymphomas. Semin Oncol 20: 89-95, 1993
28. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987-994, 1993
29. Yanagihara ET, Blaisdell RK, Hayashi T, Lukes RJ: Malignant lymphoma in Hawaii-Japanese: a retrospective morphologic survey. Hematol Oncol 7: 219-232, 1989
30. Hanai A, Fujimoto I: Cancer incidence in Japan in 1975 and changes of epidemiological features for cancer in Osaka. National Cancer Institute Monographs 62: 3-7, 1982
31. Rosenberg SA: Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities. J Clin Oncol 3: 299-310, 1985
32. Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, Malpas JS, Lister TA: Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 4: 1470-1480, 1986
33. Horning SJ: Treatment approaches to the low-grade lymphomas. Blood 83: 881-884, 1994
34. Dana BW, Dahlberg S, Nathwani BN, Chase E, Coltman C, Miller TP, Fisher RI: Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 11: 644-651, 1993
35. Cabanillas F, Smith T, Bodey GP, Gutterman JU, Freireich EJ: Nodular malignant lymphomas: factors affecting complete response rate and survival. Cancer 44: 1983-1989, 1979
36. Soubeyran P, Eghbali H, Bonichon F, Trojani M, Richaud P, Hoerni B: Low-grade follicular lymphomas: analysis of prognosis in a series of 281 patients. Eur J Cancer 27: 1606-1613, 1991
37. Litam P, Swan F, Cabanillas F, Tucker SL, McLaughlin P, Hagemeister FB, Rodriguez MA, Velasquez WS: Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Ann Intern Med 114: 855-860, 1991
38. Bastion Y, Berger F, Bryon PA, Felman P, Ffrench M, Coiffier B: Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years. Ann Oncol 2: 123-129, 1991
39. Leonard RC, Hayward RL, Prescott RJ, Wang JX: The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma: the Scotland and Newcastle Lymphoma Group Therapy Working Party. Ann Oncol 2: 655-662, 1991
40. Griffin NR, Howard MR, Quirke P, O'Brien CJ, Child JA, Bird CC: Prognostic indicators in centroblastic-centrocytic lymphoma. J Clin Pathol 41: 866-870, 1988
41. Weisdorf DJ, Andersen JW, Click JH, Oken MM: Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation. J Clin Oncol 10: 942-947, 1992
42. Steward WP, Crowther D, McWilliam LJ, Jones JM, Deakin DP, Todd ID, Blackledge G, Wagstaff J, Scarffe JH, Harris M: Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma: a randomized prospective study with an assessment of prognostic factors. Cancer 61: 441-447, 1988
43. Romaguera JE, McLaughlin P, North L, Dixon D, Silvermintz KB, Garnsey LA, Velasquez WS, Hagemeister FB, Cabanillas F: Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. J Clin Oncol 9: 762-769, 1991
44. McLaughlin P, Fuller LM, Velasquez WS, Butler JJ, Hagemeister FB, Sullivan-Halley JA, Dixon DO: Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen. J Clin Oncol 5: 867-874, 1987
45. Ezdinli EZ, Costello WG, Kucuk O, Berard CW: Effect of the degree of nodularity on the survival of patients with nodular lymphomas. J Clin Oncol 5: 413-418, 1987
46. Anderson T, DeVita VT Jr, Simon RM, Berard CW, Canellos GP, Garvin AJ, Young RC: Malignant lymphoma: II prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer 50: 2708-2721, 1982
47. Lopez-Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E, Rozman C: Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12: 1343-1348, 1994
48. Bastion Y, Coiffier B: Is the international prognostic index for aggressive lymphoma patients useful for follicular lymphoma patients? (editorial). J Clin Oncol 12: 1340-1342, 1994